Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Silver nanoparticle mouthwash is an antimicrobial oral rinse containing silver nanoparticles (AgNPs), typically at a concentration of 10 ppm. It is being investigated as an alternative to chlorhexidine for the prevention of dental caries, particularly in pediatric populations. The mechanism of action involves the broad-spectrum antimicrobial activity of silver ions and nanoparticles, which disrupt bacterial cell membranes, inhibit enzyme activity, and interfere with DNA replication in pathogens like *Streptococcus mutans*. Unlike chlorhexidine, it aims to provide effective biofilm control without common side effects such as tooth staining or taste alteration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on silver nanoparticle mouthwash.